resourcing

Job Basket

Please browse our site for vacancies then sign up

Sign Up Anyway
News Pharmacy News Optometry News
Eye on Testing Times AMD Under the Telescope Central Retinal Vein Occlusion gets a By-Pass Optegra Expands in Hampshire Eye Love Local! Headteachers Targeted by Campaign Manchesters Heroes Going the extra mile for VAO Ocutec secures further funding for new contact lens Huge sum is invested in Optical Express clinics Advice Course for Pre-reg Optometrists Optegra buys Yorkshire Eye Hospital Asda focus on Contact Lens market Eye surgeon calls for Avastin on the NHS Vision CRC breakthrough technology controls myopia in children AOP help Optoms Avoid Costly De-Registration GOC to consult on new CET scheme from 2013 Optometry Scotland Roadshow- Last chance to book Vision UK 2010 Conference Women in optics on the increase Boots Named Top Place to Work by The Sunday Times Green Tea May Ward Off Eye Disease Glaucoma Begins in Mid-Brain, Not in Eye, Research Shows AOP Student Conference 2010 Economies and eye health to be debated in March Smoker’s risk of eye disease should be discussed by optometrist Anglia suspends 2010 dispensing courses EPIC eye care scheme launched Results of a New Femtosecond Laser Treatment for Presbyopia Use of Glaucoma Medication Linked to Reduced Likelihood of Death Eye Damage From Diabetes Remains The Leading Cause Of Blindness In Adults In The US Boots Axes Final Salary Pension for 15,000 Workers UV-Blocking CLs Cut Acute Exposure Risk Parents miss Importance of Eye Exam Essex Eye Tests Cancelled Glaucoma drug ‘could do the job of mascara’ Rebranding with Confidence- Boots put Employees High on the Agenda Vision Express Expansion in India New Codes of Conduct: what to expect from your optician Alzheimer's disease 'could be detected by eye test' Medical Detectives Focus On Myopia New bulbs not such a bright idea New sunglasses can also be used for 3-D viewing Research to help those with impaired vision praised Monocles are the new fashion statement? Practice arrests leave patients without specs Specsavers sees pre-tax profits rise 3pc Boots to rebrand most D&A sites by end 2010 Aston University Researchers Receive Stimulus Shadow Health Minister Andrew Davies argues for better eye testing Optometrists in Ireland Stopping of Glasses Scheme Criticised Boots celebrates 160th anniversary Simple eye test at Specsavers saved my life, says tumour survivor Eye expert helps thousands see properly again in Africa Man blinded during Blitz regains sight One third of British drivers could be on the roads with sub-standard vision Operation to see in HD Brief Histiry of Laser Eye Treatment Vision Care website will expand into Europe Eye floaters may cause loss of vision Over-the-Counter Eye Drops Raise Concern About Antibiotic Resistance Early Diagnosis of Ocular Pathologies Such as Keratitis and Macular Degeneration Now Possible Scientists rescued visual function in laboratory rats India; Optometry students threaten protest
Dentistry News

Scientists rescued visual function in laboratory rats

Rat-Eye

 

An international team of scientists has rescued visual function in laboratory rats with eye disease by using cells similar to stem cells. The research shows the potential for stem cell-based therapies to treat age-related macular degeneration in humans.

A team led by Dennis Clegg, of UC Santa Barbara, and Pete Coffey, of University College London (UCL), published their work in two papers, including one published the week of December 1 in the journal PloS One. The first paper was published in the October 27 issue of the journal Stem Cells.

The scientists worked with rats that have a mutation which causes a defect in retinal pigmented epithelial (RPE) cells and leads to photoreceptor death and subsequent blindness. Human RPE cells were derived from induced pluripotent stem cells -- embryonic stem cell-like cells that can be made from virtually any cell in the body, thus avoiding the controversy involved in using stem cells derived from embryos. Pluripotent means that the cells can become almost any cell in the body.

In experiments spearheaded by UCL's Amanda Carr, the team found that by surgically inserting stem cell-derived RPE into the retinas of the rats before photoreceptor degeneration, vision was retained. They found that the rats receiving the transplant tracked their visual focus in the direction of moving patterns more efficiently than control groups that did not receive a transplant.

"Although much work remains to be done, we believe our results underscore the potential for stem-cell based therapies in the treatment of age-related macular degeneration," said Sherry Hikita, an author on both papers and director of UCSB's Laboratory for Stem Cell Biology.

Dave Buchholz, first author of the article in Stem Cells, explained that by using induced stem cells that can be derived from patients, the scientists avoid immune rejection that might occur when using embryonic stem cells.

According to Buchholz, "RPE cells are essential for visual function. Without RPE, the rod and cone photoreceptors die, resulting in blindness. This is the basic progression in age-related macular degeneration. The hope is that by transplanting fresh RPE, derived from induced pluripotent stem cells, the photoreceptors will stay healthy, preventing vision loss."

RELATED NEWS:

Early Diagnosis of Ocular Pathologies Such as Keratitis and Macular Degeneration Now Possible

Shadow Health Minister Andrew RT Davies argues for better screening

Specsavers sees pre-tax profits rise 3pc